Your browser doesn't support javascript.
loading
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.
Nabi, Oumarou; Lapidus, Nathanaël; Boursier, Jerome; de Ledinghen, Victor; Petit, Jean-Michel; Kab, Sofiane; Renuy, Adeline; Zins, Marie; Lacombe, Karine; Serfaty, Lawrence.
Afiliação
  • Nabi O; Washington University in St Louis School of Medicine, Saint Louis, Missouri, USA.
  • Lapidus N; Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France.
  • Boursier J; Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France.
  • de Ledinghen V; Hepatogastroenterology Department, Anger University Hospital, Angers, France.
  • Petit JM; HIFIH Laboratory, UPRES EA3859, SFR 4208, Angers University, Angers, France.
  • Kab S; Bordeaux University Hospital Branch, Bordeaux, France.
  • Renuy A; Department of Endocrinology-Diabetology, Dijon University Hospital, Dijon, France.
  • Zins M; Versailles-Saint Quentin University, UMS 11 Inserm, France.
  • Lacombe K; Versailles-Saint Quentin University, UMS 11 Inserm, France.
  • Serfaty L; Versailles-Saint Quentin University, UMS 11 Inserm, France.
Hepatology ; 79(5): E130-E131, 2024 May 01.
Article em En | MEDLINE | ID: mdl-38252803

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2024 Tipo de documento: Article